NCT00186394View on ClinicalTrials.gov

High Dose Chemotherapy and Allogeneic Hematopoietic Cell Transplant for Non-Hodgkin's Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

April 30, 2000

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions
Lymphoma, Non-HodgkinBlood and Marrow Transplant (BMT)Lymphomas: Non-Hodgkin
Interventions
PROCEDURE

ablative allogeneic hematopoietic cell transplantation

Trial Locations (1)

94305

Stanford University School of Medicine, Stanford

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

Stanford University

OTHER

NCT00186394 - High Dose Chemotherapy and Allogeneic Hematopoietic Cell Transplant for Non-Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter